Duke University, Department of Biomedical Engineering, 136 Hudson Hall, Box 90281, Durham, North Carolina 27708, USA.
J Biomed Opt. 2009 Sep-Oct;14(5):054051. doi: 10.1117/1.3251013.
Noninvasive and longitudinal monitoring of tumor oxygenation status using quantitative diffuse reflectance spectroscopy is used to test whether a final treatment outcome could be estimated from early optical signatures in a murine model of head and neck cancer when treated with radiation. Implanted tumors in the flank of 23 nude mice are exposed to 39 Gy of radiation, while 11 animals exposed to sham irradiation serve as controls. Diffuse optical reflectance is measured from the tumors at baseline (prior to irradiation) and then serially until 17 days posttreatment. The fastest and greatest increase in baseline-corrected blood oxygen saturation levels are observed from the animals that show complete tumor regression with no recurrence 90 days postirradiation, relative to both untreated and treated animals with local recurrences. These increases in saturation are observed starting 5 days posttreatment and last up to 17 days posttreatment. This preclinical study demonstrates that diffuse reflectance spectroscopy could provide a practical method far more effective than the growth delay assay to prognosticate treatment outcome in solid tumors and may hold significant translational promise.
使用定量漫反射光谱技术无创且纵向监测肿瘤氧合状态,以测试在接受放射治疗的头颈部癌症小鼠模型中,早期光学特征是否可用于估计最终的治疗结果。将植入的肿瘤置于 23 只裸鼠的侧腹,接受 39Gy 的辐射,而 11 只接受假照射的动物作为对照。在基线(照射前)和随后的时间点测量肿瘤的漫射光反射,直到治疗后 17 天。与未治疗和局部复发的治疗动物相比,在 90 天治疗后完全消退且无复发的动物中,观察到基线校正后的血氧饱和度水平增加最快且最大。这些饱和度的增加从治疗后 5 天开始,持续到治疗后 17 天。这项临床前研究表明,漫反射光谱技术可能比生长延迟测定更有效地提供一种实用方法,以预测实体瘤的治疗结果,并具有重要的转化前景。